EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Pemphigoid gestationis after egg donation: A case report and literature review

Hiroshi Koga iD, Masahiro Tsutsumi, Norito Ishii, Megumi Muto, Takekuni Nakama

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-11 · 22 (11) · 1560-1564

DOI: 10.1111/ddg.15542 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 10.09.2024. Verfasst von Hiroshi Koga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editors, Pemphigoid gestationis (PG), formerly known as herpes gestationis, is a rare subepidermal autoimmune blistering disease occurring during pregnancy, usually in the second or third trimester. PG presents with pruritic urticarial plaques and/or vesiculobullous lesions, typically originating in the periumbilical region. Linear deposits of complement and/or IgG in the epidermal basement membrane zone (BMZ) revealed by direct immunofluorescence and circulating anti-BP180 antibodies are hallmarks of PG. In rare cases, PG develops during pregnancy after ovodonation. A 51-year-old Japanese woman in her 30th week of pregnancy was referred to our department with pruritic eruptions and vesicles. This was her second in vitro fertilization pregnancy, following one year after the previous pregnancy and using material from the same unrelated egg donor and the patient's husband. No dermatological manifestaions were noted during the first pregnancy. Her medical history included ulcelative colitis at the age of 20 and hyperlipemia without medication. Preeclampsia was noted. In addition, peripheral eosinophilia had been observed for two years. She presented with pruritic papules and erythema in the periumbilical region and extremities, with vesicles and bullae (Figure 1a,b). Histological examination revealed a subepidermal bulla with eosiniophilic infiltration in the blister and perivascular infiltration in the dermis (Figure 1c,d). Direct immunofluorescence assays revealed linear IgG and C3 depositions in the epidermal basement membrane zone (BMZ) (Figure 2a). The activity of BP180 by chemiluminescence enzyme immunoassay (CLEIA) was 148 U/ml, whereas the enzyme-linked immunosorbent assay (ELISA) for BP230 was negative (4.19 index). In the immunofluorescence assay using normal human skin, the patient's IgG reacted with the cell surface of keratinocytes (Figure 2b). However, ELISAs for desmoglein 1 and 3 and desmocollin 1–3 were all negative. Indirect immunofluorescence using 1 M NaCl split skin revealed an IgG reaction on the epidermal side (Figure 2c). Further immunoblotting analyses using epidermal extract, the recombinant C-terminal protein fragment of BP180, and concentrated HaCaT cell culture supernatant were all negative with the patient's IgG. She was diagnosed with PG and treated with oral prednisolone 15 mg/day, which improved her symptoms. At 36+0 weeks' gestation, she underwent a cesarean section for premature rupture of the membranes and gave birth to a male infant weighing 2,595 g with no skin manifestations. The skin symptoms did not relapse after delivery, and the oral prednisolone was tapered off. BP180 activity decreased to 20.1 U/ml in CLEIA, while peripheral eosinophilia continued. The cause of PG remains unclear, but a cross-reaction between placental and skin BP180 may result in PG, as placental and foetal tissues have paternal antigens (semi-allogenic), which are HLA mismatches for the maternal immune system.1 Genetic predispositions to PG, maternal DRB1*0301 (HLA-DR3), DRB1*0401/040X (HLA-DR4), and their combinations have been reported. PG disease activity may be modulated by progesterone, as progesterone levels decrease toward the end of pregnancy when disease activity decreases.2 Semi-allogenicity between foetal and maternal tissue is tolerated by an immune-privileged site at the foetal-maternal interface during spontaneously conceived pregnancy. However, pregnancy after ovodonation is associated with a higher degree of HLA mismatches and antigenic dissimilarity than spontaneously conceived pregnancy, which might be a risk for PG.1 Egg donation increases risks of preeclampsia and gestational hypertension, which are associated with immunological intolerance,3 and preeclampsia is associated with a number of fetal-maternal HLA mismatches.4 Unexpectedly, complications during pregnancy were reported in only two cases, including our case. A systematic review found that only two of 140 PG patients were pregnancies achieved after ovodonation. PG after ovodonation rarely develops, but the prevalence of PG in pregnancies after ovodonation remains unknown. To the best of our knowledge, only three cases of PG after ovodonation have been reported (Table 1).1, 5, 6 The gestational times were similar to those reported for PG without ovodonation. Interestingly, three of these four cases developed during their second pregnancy (G2P1), while a systematic review showed that 45.7% of PG was developed at primipara. Repeated pregnancies after ovodonation may be a risk factor for PG. Histopathology showed edema in the dermis and lymphocytic inflammation with or without eosinophils, although the findings varied between the cases. BP180 antibody tests were positive, but BP230 antibody tests were negative in all three cases tested. We previously reported that BP230 ELISA positivity was low (16%) in PG.7 All patients achieved complete remission after delivery, with no skin manifestations in the infants, all of whom were male. In this study, the clinical and immunologic characteristics of both our case and those reported in the literature were evaluated. PG after ovodonation is rare and further accumulation of cases is needed to analyze whether pregnancy after ovodonation is a risk factor for PG. IgG: deposit in subcorneal blisters C3: deposit at BMZ BP180 CLEIA (MBL): positive (148 U/ml) BP230 ELISA (MBL): negative None.

Schlagwörter

Stichwörter der Autor:innen

BP180ovodonationpemphigoid gestationispregnancy

Autor:innen und Institutionen

  • Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.

ORCID-Profile: Hiroshi Koga

Zitieren

APA

Koga, H., Tsutsumi, M., Ishii, N., Muto, M., & Nakama, T. (2024). Pemphigoid gestationis after egg donation: A case report and literature review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(11), 1560-1564. https://doi.org/10.1111/ddg.15542

Vancouver

Koga H, Tsutsumi M, Ishii N, Muto M, Nakama T. Pemphigoid gestationis after egg donation: A case report and literature review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(11):1560-1564. doi:10.1111/ddg.15542

BibTeX
@article{Koga2024,
  author = {Koga, Hiroshi and Tsutsumi, Masahiro and Ishii, Norito and Muto, Megumi and Nakama, Takekuni},
  title = {Pemphigoid gestationis after egg donation: A case report and literature review},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  volume = {22},
  number = {11},
  pages = {1560--1564},
  doi = {10.1111/ddg.15542}
}
Kostenlos starten →